Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/03/2003US6571856 Method for predicting the microstructure of solidifying cast iron
06/03/2003US6571651 Method of preventing short sampling of a capillary or wicking fill device
06/03/2003US6571648 Method of accelerated aging of neat asphalt binder using microwave radiation process
06/03/2003US6571611 High temperature diesel fuel test apparatus and method
06/03/2003US6571603 Method of resolving analytes in a fluid
06/03/2003US6571601 Method for determining the reducing agent concentration (NH3) in the exhaust-gas flow of an internal combustion engine
06/03/2003US6571600 Apparatus and method for measurement of coefficient of restitution and contact time
06/03/2003CA2185574C Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
05/2003
05/30/2003WO2003044825A1 High resolution automated maldi data analysis
05/30/2003WO2003044607A1 Method and apparatus for predicting polymer latex properties in an emulsion polymerization process to improve the quality and productivity of the polymer latex
05/30/2003WO2003044537A1 Device and method for treating magnetic particles
05/30/2003WO2003044536A1 Method for evaluation of the risk of cardiovascular disease
05/30/2003WO2003044535A1 Method, antigen and antibody for distinguishing viable and apoptotic cells
05/30/2003WO2003044534A1 Immunochromatographic test strip for measuring analysis subject in specimen in trace amount
05/30/2003WO2003044533A2 Capture and detection phase of a target biological material for elisa tests
05/30/2003WO2003044532A1 Method for detecting analyte(s) using magnetic colloidal particles
05/30/2003WO2003044531A2 Functionalised support card and use thereof for the rapid diagnosis of an infarct based on an immunotest
05/30/2003WO2003044530A1 Sensor system with a reference surface mimicking the detection surface but with low ligand binding capacity
05/30/2003WO2003044529A1 Modulators of lymphocyte activation, mkk3b compositions and methods of use
05/30/2003WO2003044528A2 Flow-controlled magnetic particle manipulation
05/30/2003WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport
05/30/2003WO2003044523A1 Method of detecting malignant tumor and detection kit
05/30/2003WO2003044521A1 Rfid spoilage sensor for packaged food and drugs
05/30/2003WO2003044519A1 Separation apparatus, method of separation, and process for producing separation apparatus
05/30/2003WO2003044518A1 Method of determining cationic surfactant
05/30/2003WO2003044515A1 Analysing spots in a 2-d array
05/30/2003WO2003044514A1 Fail judging method for analysis and analyzer
05/30/2003WO2003044513A1 Fail judging method and analyzer
05/30/2003WO2003044511A2 Construction and use of micro-electrode arrays
05/30/2003WO2003044503A1 Fluid analyser systems
05/30/2003WO2003044494A1 Method for determinig whether a fluid in an air-conditioning or refrigeration system has been altered
05/30/2003WO2003044493A1 Method for the determination of substances in a liquid or gaseous sample
05/30/2003WO2003044490A2 Method for identifying substances in a liquid or gaseous sample
05/30/2003WO2003044489A1 Cone plate type cell separation evaluating device
05/30/2003WO2003044485A2 Proteonomic methods for diagnosis and monitoring of breast cancer
05/30/2003WO2003044481A2 Optical bio-discs and microfluidic devices for analysis of cells
05/30/2003WO2003044453A1 Measurement of the thickness of metals using a spectrum of electromagnetic frequencies and magnetic saturation
05/30/2003WO2003044232A1 Method of detection of prostate cancer
05/30/2003WO2003044231A1 Method and kit for proximity probing with multivalent proximity probes
05/30/2003WO2003044230A1 Method and kit for detection of novel pathogen inhibitors
05/30/2003WO2003044225A2 Profiling of the immune gene repertoire
05/30/2003WO2003044224A1 Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
05/30/2003WO2003044221A1 Microfluidic system for proteome analysis
05/30/2003WO2003044220A1 Total cysteine assay
05/30/2003WO2003044218A1 Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
05/30/2003WO2003044217A2 Automated sample preparation methods and devices
05/30/2003WO2003044213A2 Cell and tissue arrays and microarrays and methods of use
05/30/2003WO2003044196A1 Postsynaptic proteins
05/30/2003WO2003044182A1 CELLS EXPRESSING gob-5 AND USE THEREOF
05/30/2003WO2003044178A2 Hybrid oligonucleotide primers for amplification of dna and uses thereof
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044158A1 Methods and devices for the integrated discovery of cell culture environments
05/30/2003WO2003044059A1 Agonists of recombinant human histamine h3 receptor
05/30/2003WO2003044054A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
05/30/2003WO2003044041A2 Alpha-fetoprotein peptides and uses for imaging
05/30/2003WO2003044040A2 Alpha-fetoprotein peptides and uses thereof
05/30/2003WO2003044036A1 Tumor specific monoclonal antibodies
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003043978A2 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
05/30/2003WO2003043931A1 Artificial structures with magnetic functionality
05/30/2003WO2003043713A1 Size-exclusion filtering device, method for making same and resulting filtering method
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043631A2 Method for identification of tumor targeting enzymes
05/30/2003WO2003043580A2 Methods for identifying and validating potential drug targets
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003043568A2 Compositions and methods for the suppression of mammary epithelial cell proliferation
05/30/2003WO2003043524A2 Compositions and methods for accurate early pregnancy diagnosis
05/30/2003WO2003043487A2 Method of using a non-antibody protein to detect and measure an analyte
05/30/2003WO2003043403A2 Methods and apparatus for blood typing with optical bio-discs
05/30/2003WO2003027281A3 Pluripotent stem cells originating in skeletal muscle intestinal tissue
05/30/2003WO2003025565A3 Preparation of highly-purified plasma membranes
05/30/2003WO2003025204A3 Biochip assembly, sensor assembly and method for operating a biochip assembly
05/30/2003WO2003017048A3 A method of screening for disorders of glucose metabolism
05/30/2003WO2003016917A3 Sodium channel regulators and modulators
05/30/2003WO2003009667A3 Animal consumable labeling and method thereof
05/30/2003WO2003008979A3 Method to purify prion protein using nuclease
05/30/2003WO2003008933A3 Test strip for a lateral flow assay
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
05/30/2003WO2003001204A3 Type 1 diabetes diagnostics and therapeutics
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002100805A3 Colorimetric nanocrystal sensors, methods of making, and use thereof
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002099425A3 Polymeric bead probe with nanocrystal, manufacture and use of the same
05/30/2003WO2002098891A3 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002095418A3 Method of examining and diagnosing skin health
05/30/2003WO2002095380A3 Method for determining a physical mass changing event
05/30/2003WO2002095363A3 Methods for attenuation of virulence in bacteria
05/30/2003WO2002092776A3 Methods for the indentification of inhibitors of 2-hydroxyisoflavone reductase expression or activity in plants
05/30/2003WO2002090961A3 Systems and methods for detection of analytes in biological fluids
05/30/2003WO2002086504A3 Individualization of therapy with gastroesophageal reflux disease agents
05/30/2003WO2002079786A3 Method for identifying drugs for the treatment of type ii diabetes
05/30/2003WO2002076501A3 Blood cell production via activation of the hemoglobin scavenger receptor
05/30/2003WO2002073198A3 Non-separation assay and system using opaque particles
05/30/2003WO2002073196A3 Individualization of therapy with antipsychotics
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003WO2002070020A3 Polymer precursors of radiolabeled compounds, and methods of making and using the same
1 ... 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 ... 3937